An underground market for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.
Experimental Treatment Acquiring Traction Via Social Media
The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts directly for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where communities with thousands of participants share comparison photos, injection guides and claims of next-day UK delivery. Sellers market the drug there before directing customers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Voice Concerns
However, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering products of uncertain source.
Some experts stated the demand for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.
Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.
Service Reaction and Material Elimination
According to TikTok, the service has taken down problematic content and banned related hashtags and query recommendations. The company said it was committed to maintaining the service secure and investing in strengthening compliance measures.
Online Trading Operations
Investigations also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays channels with numerous of members, filled with photos of slimming results, glowing reviews and detailed instructions for preparing or injecting at residence.
After minutes of joining one group, a seller posted contact information, where the majority of purchases occur. The vendor provided an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.
Product Information and Pricing
Within these communities, posts show black plastic packages with Royal Mail labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When asked how long a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram stated it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering materials they cannot confirm. Even if the research behind this drug is sound, these online products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has previously encountered individuals harmed by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”
Producer Statement
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject patients to potentially serious health risks”.
